Vitamin D supplementation reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind, randomized, placebo-controlled trial

Nutrition Research

Volumn 36, Issue 10, 2016, Pages 1121-1129

  Sun, Xiaomin ^a   Cao, Zhen Bo ^a,b   Tanisawa, Kumpei ^a   Ito, Tomoko ^a   Oshima, Satomi ^a   Higuchi, Mitsuru ^a  

^a WASEDA UNIVERSITY   (Japan)

^b SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

25(OH)D; Insulin resistance; Percent body fat; Physical activity; Visceral fat area

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; GLUCOSE; INSULIN; PARATHYROID HORMONE; PLACEBO; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CARDIORESPIRATORY FITNESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVALUATION STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAPERITONEAL FAT; JAPANESE (PEOPLE); LIPID STORAGE; MALE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIET RESTRICTION; DIETARY SUPPLEMENT; JAPAN; METABOLISM; MIDDLE AGED; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; REFERENCE VALUES; VITAMIN D;

EID: 84992187918     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.07.006     Document Type: Article

References (48)

1. [1] Shaw, JE, Sicree, RA, Zimmet, PZ, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87 (2010), 4–14.
2. [2] Stumvoll, M, Goldstein, BJ, van Haeften, TW, Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 (2005), 1333–1346.
3. [3] Eliades, M, Pittas, AG, Vitamin D and type 2 diabetes. Clin Rev Bone Miner Metab 7 (2009), 185–198.
4. [4] Sun, X, Cao, ZB, Tanisawa, K, Ito, T, Oshima, S, Higuchi, M, The relationship between serum 25-hydroxyvitamin D concentration, cardiorespiratory fitness, and insulin resistance in Japanese men. Nutrients 7 (2014), 91–102.
5. [5] Sun, X, Cao, ZB, Tanisawa, K, Ito, T, Osima, S, Ishimi, Y, et al. Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men. J Atheroscler Thromb 22 (2015), 355–362.
6. [6] Hypponen, E, Power, C, Vitamin D status and glucose homeostasis in the 1958 British birth cohort—the role of obesity. Diabetes Care 29 (2006), 2244–2246.
7. [7] Chiu, KC, Chu, A, Go, VLW, Saad, MF, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004), 820–825.
8. [8] Scragg, R, Sowers, M, Bell, C, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004), 2813–2818.
9. [9] Forouhi, NG, Luan, J, Cooper, A, Boucher, BJ, Wareham, NJ, Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance—the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57 (2008), 2619–2625.
10. [10] Mattila, C, Knekt, P, Maennistoe, S, Rissanen, H, Laaksonen, MA, Montonen, J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30 (2007), 2569–2570.
11. [11] Gagnon, C, Lu, ZX, Magliano, DJ, Dunstan, DW, Shaw, JE, Zimmet, PZ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34 (2011), 1133–1138.
12. [12] Oosterwerff, MM, Eekhoff, EMW, Van Schoor, NM, Boeke, AJP, Nanayakkara, P, Meijnen, R, et al. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D–deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial. Am J Clin Nutr 100 (2014), 152–160.
13. [13] Nagpal, J, Pande, JN, Bhartia, A, A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D-3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26 (2009), 19–27.
14. [14] von Hurst, PR, Stonehouse, W, Coad, J, Vitamin D supplementation reduces insulin resistance in south Asian women living in New Zealand who are insulin resistant and vitamin D deficient—a randomised, placebo-controlled trial. Br J Nutr 103 (2010), 549–555.
15. [15] Grimnes, G, Figenschau, Y, Almas, B, Jorde, R, Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 60 (2011), 2748–2757.
16. [16] Wood, AD, Secombes, KR, Thies, F, Aucott, L, Black, AJ, Mavroeidi, A, et al. Vitamin D-3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 97 (2012), 3557–3568.
17. [17] Wamberg, L, Kampmann, U, Stodkilde-Jorgensen, H, Rejnmark, L, Pedersen, SB, Richelsen, B, Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels—results from a randomized trial. Eur J Intern Med 24 (2013), 644–649.
18. [18] Scragg, R, Camargo, CA Jr., Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 168 (2008), 577–586.
19. [19] Kluczynski, MA, Lamonte, MJ, Mares, JA, Wactawski-Wende, J, Smith, AW, Engelman, CD, et al. Duration of physical activity and serum 25-hydroxyvitamin D status of postmenopausal women. Ann Epidemiol 21 (2011), 440–449.
20. [20] Brock, K, Cant, R, Clemson, L, Mason, RS, Fraser, DR, Effects of diet and exercise on plasma vitamin D (25(OH)D) levels in Vietnamese immigrant elderly in Sydney, Australia. J Steroid Biochem Mol Biol 103 (2007), 786–792.
21. 3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol 2 (1992), 697–703.
22. [22] Abboud, M, Puglisi, DA, Davies, BN, Rybchyn, M, Whitehead, NP, Brock, KE, et al. Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 154 (2013), 3022–3030.
23. [23] Sieverdes, JC, Sui, XM, Lee, DC, Church, TS, McClain, A, Hand, GA, et al. Physical activity, cardiorespiratory fitness and the incidence of type 2 diabetes in a prospective study of men. Br J Sports Med 44 (2010), 238–244.
24. [24] Warburton, DER, Nicol, CW, Bredin, SSD, Health benefits of physical activity: the evidence. Can Med Assoc J 174 (2006), 801–809.
25. [25] Borghouts, LB, Keizer, HA, Exercise and insulin sensitivity: a review. Int J Sports Med 21 (2000), 1–12.
26. [26] Yoon, KH, Lee, JH, Kim, JW, Cho, JH, Choi, YH, Ko, SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006), 1681–1688.
27. [27] Cao, ZB, Miyatake, N, Higuchi, M, Miyachi, M, Tabata, I, Predicting VO(2max) with an objectively measured physical activity in Japanese men. Eur J Appl Physiol 109 (2010), 465–472.
28. [28] Friedewa, W, Fredrick, DS, Levy, RI, Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
29. [29] Wortsman, J, Matsuoka, LY, Chen, TC, Lu, Z, Holick, MF, Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000), 690–693.
30. [30] Vieth, R, Ladak, Y, Walfish, PG, Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88 (2003), 185–191.
31. [31] Gloth, FM III, Tobin, JD, Vitamin D deficiency in older people. J Am Geriatr Soc 43 (1995), 822–828.
32. 3 supplementation: a meta-regression analysis. Nutrition 30 (2014), 975–985.
33. [33] Kodama, K, Tojjar, D, Yamada, S, Toda, K, Patel, CJ, Butte, AJ, Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 36 (2013), 1789–1796.
34. [34] Haskell, WL, Lee, IM, Pate, RR, Powell, KE, Blair, SN, Franklin, BA, et al. Physical activity and public health—updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116 (2007), 1081–1093.
35. [35] Song, Q, Sergeev, IN, Calcium and vitamin D in obesity. Nutr Res Rev 25 (2012), 130–141.
36. [36] Hogan, PG, Chen, L, Nardone, J, Rao, A, Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17 (2003), 2205–2232.
37. [37] Zittermann, A, Frisch, S, Berthold, HK, Gotting, C, Kuhn, J, Kleesiek, K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89 (2009), 1321–1327.
38. [38] Zhou, QG, Hou, FF, Guo, ZJ, Liang, M, Wang, GB, Zhang, X, 1, 25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 24 (2008), 459–464.
39. [39] Reis, JP, von Muhlen, D, Kritz-Silverstein, D, Wingard, DL, Barrett-Connor, E, Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30 (2007), 1549–1555.
40. [40] Chiu, KC, Chuang, LM, Lee, NP, Ryu, JM, McGullam, JL, Tsai, GP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49 (2000), 1501–1505.
41. [41] Barnes, MS, Horigan, G, Cashman, KD, Hill, TR, Forsythe, LK, Lucey, AJ, et al. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr 141 (2011), 476–481.
42. [42] Jorde, R, Sneve, M, Torjesen, PA, Figenschau, Y, Goransson, LG, Omdal, R, No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50 (2010), 175–180.
43. [43] Ross, AC, Manson, JE, Abrams, SA, Aloia, JF, Brannon, PM, Clinton, SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96 (2011), 53–58.
44. [44] Japanese Ministry of Health, Labour, and Welfare, Dietary reference intakes for Japanese 2010. 2009, Daiichi Shuppan Publishing Co. Ltd., Tokyo, Japanese.
45. [45] Barger-Lux, MJ, Heaney, RP, Dowell, S, Chen, TC, Holick, MF, Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8 (1998), 222–230.
46. [46] Zittermann, A, Ernst, JB, Gummert, JF, Borgermann, J, Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr 53 (2014), 367–374.
47. [47] Girgis, CM, Clifton-Bligh, R, Turner, N, Lau, SL, Gunton, JE, Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 80 (2014), 169–181.
48. [48] Barker, T, Rogers, VE, Levy, M, Templeton, J, Goldfine, H, Schneider, ED, et al. Supplemental vitamin D increases serum cytokines in those with initially low 25-hydroxyvitamin D: a randomized, double blind, placebo-controlled study. Cytokine 71 (2015), 132–138.